SCHEMBL1732928

SCHEMBL1732928

Nc1nc2c(ncn2C/C=C/CCP(=O)(O)O)c(=O)[nH]1

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 13/20 0.67
PNP P00491 7/20 0.65
TK1 P04183 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11374638 1.00 HPRT1 (0.67) HPRT1PNPTK1
SCHEMBL1732931 1.00 HPRT1 (0.67) HPRT1PNPTK1
Butane SCHEMBL1733010 0.96 HPRT1 (0.62) HPRT1PNP
SCHEMBL11307091 0.91 HPRT1 (0.58) HPRT1PNPTK1
SCHEMBL6834474 0.84 HPRT1 (0.66) HPRT1PNPTK1
SCHEMBL6834479 0.84 HPRT1 (0.66) HPRT1PNPTK1
SCHEMBL11387280 0.83 PNP (0.55) HPRT1PNP
SCHEMBL10506150 0.83 TK1 (0.71) HPRT1PNPTK1
SCHEMBL10506159 0.83 TK1 (0.71) HPRT1PNPTK1
SCHEMBL10508175 0.83 TK1 (0.71) HPRT1PNPTK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222257-B2 Phosphono-pent-2-en-1-yl nucleosides and analogs THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-07-17 US disclosed
EP-1866319-B1 PHOSPHONO-PENT-2-EN-1-YL NUCLEOSIDES AND ANALOGS UNIV CALIFORNIA (US) 2011-11-23 EP disclosed
US-20090215726-A1 Phosphono-Pent-2-en-1-yl Nucleosides and Analogs NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215726-A1 Phosphono-Pent-2-en-1-yl Nucleosides and Analogs PNP, TYMP, ENPP1 HPRT1 215/4885PNP 1/4885TK1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.